Taiwan Liposome Company, Ltd. announced that its Board of directors resolved to set up TLC Biopharmaceuticals (Japan) Company, Ltd. in Japan, which is owned 100% by the company. The capital of this subsidiary is ¥10,000,000.
Taiwan Liposome Company, Ltd.
Equities
4152
TW0004152004
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |